Word: corlis
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...strange cities. But for those who missed the Internet boom and its resplendent wonders, this one-part exciting and two-parts vertiginous lifestyle has been conveniently encapsulated at the Blue Room. This bustling Kendall Square restaurant is just two T stops away, but with an unremarkable décor and unplaceable cuisine, it seems a faceless world unto itself...
...does the ability to suspend the desire for coherence, which really can get tiresome at times. The feelingless anonymity of the dining room should appeal as a dating scene for either sexual deviants or true romantics. The couple deeply in love does not need roses and cozy décor in order to swoon over each other, nor does the interesting conversationalist require sensory overload in order to invigorate his companion. The Blue Room’s sparse brick walls offer only bizarre Betsy Cullen photographs for distraction, so if you come, bring your A-game, order a quart...
...They are genuinely excited for futures filled with jobs, rent payments, car payments, kitchenettes and blind dates. These seniors are what I like to call masochistic freaks. Sure, there are some things about college life that I’d gladly give up, Boston weather and cinderblock décor being #1 and #2, but beyond that, Harvard has done me pretty well...
...Cambridge, 1 is a very welcome addition to the Harvard Square scene. When you think about it, it’s upsetting that other places cannot follow their simple recipe for success. No real culinary rocket science is going on in the kitchen, after all, and the décor is an exceedingly understated blend of a sauna and a factory. The beauty is that Cambridge, 1 does not aim too high, but also does not fall into the same bland banality of most restaurants in its price range. It is by no means a unique dining experience...
Millennium Pharmaceuticals of Cambridge, Mass., has been a step ahead of most competitors. It announced on Dec. 6 the acquisition of COR Therapeutics of South San Francisco, Calif., for a stock swap worth $2 billion--the largest in biotech history and Millennium's fourth acquisition in as many years. That was just the latest in a series of mergers that have changed the face of the industry. Last month Celera Genomics, once the quintessential genetic information-services company, paid $174 million for Axys Pharmaceuticals of South San Francisco, a master designer of drugs. Another major information-services firm, Incyte Genomics...